| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2008 | WO2008104532A1 Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin |
| 09/04/2008 | WO2008104524A1 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| 09/04/2008 | WO2008104512A2 Novel polymorphs of aprepitant and processes for preparation |
| 09/04/2008 | WO2008104475A1 Isoquinolinopyrrolopyridinones active as kinase inhibitors |
| 09/04/2008 | WO2008104474A1 Diaminopyrimidines |
| 09/04/2008 | WO2008104472A1 2, 4 -diaminopyrimidine derivatives and their use as p2x antagonists or as prodrugs thereof |
| 09/04/2008 | WO2008104387A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases |
| 09/04/2008 | WO2008104386A2 Method for the treatment of amyloidoses |
| 09/04/2008 | WO2008104342A1 Pharmaceutical preparation for the alleviation of endometriosis |
| 09/04/2008 | WO2008104306A2 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
| 09/04/2008 | WO2008104279A1 Imidazo[1,2-a]azines and their use as pharmaceuticals |
| 09/04/2008 | WO2008104278A1 Imidazo[1,2-a] pyridines and their use as pharmaceuticals |
| 09/04/2008 | WO2008104239A1 Composition useful for the treatment of type 2 diabetes |
| 09/04/2008 | WO2008104215A1 Oil-in-water emulsions ii which are stabilized by their active ingredient |
| 09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | WO2008104187A1 Pharmaceutical composition comprising glibenclamide coenzyme q10 and vitamins for the treatment of diabetes |
| 09/04/2008 | WO2008104186A1 Pharmaceutical composition comprising a steroid and vitamins |
| 09/04/2008 | WO2008104175A2 Novel phosphodiesterase inhibitors |
| 09/04/2008 | WO2008104161A1 ß-CARBOLINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008104084A1 Linoleoyl-containing phospholipids and methods for their use |
| 09/04/2008 | WO2008104077A1 Small molecule inhibitors of protein arginine methyltransferases (prmts) |
| 09/04/2008 | WO2008104055A1 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists |
| 09/04/2008 | WO2008090200A3 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 09/04/2008 | WO2008088864A9 Matrix metalloproteinase-9-related methods |
| 09/04/2008 | WO2008086804A3 Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| 09/04/2008 | WO2008086678A3 The medical use of levo-phencynonate as neuroprotective agent |
| 09/04/2008 | WO2008086462A3 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS |
| 09/04/2008 | WO2008084067A3 Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives |
| 09/04/2008 | WO2008083238A3 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 09/04/2008 | WO2008081104A3 Conglomerates of tenatoprazole potassium salts |
| 09/04/2008 | WO2008080965A3 Hiv inhibiting 5,6-substituted pyrimidines |
| 09/04/2008 | WO2008079814A3 Mapk/erk kinase inhibitors |
| 09/04/2008 | WO2008074834A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 09/04/2008 | WO2008070937A3 Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors |
| 09/04/2008 | WO2008063301A3 Pharmaceutical compositions |
| 09/04/2008 | WO2008063114A9 Amino- imidazolones and their use as medicament for treating cognitive impairment alzheimer disease, neurodegeneration and dementia |
| 09/04/2008 | WO2008062253A3 Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine |
| 09/04/2008 | WO2008061966A8 New use of flibanserin |
| 09/04/2008 | WO2008060622A3 Improved methods and compositions for wound healing |
| 09/04/2008 | WO2008058225A3 Methods and compositions for treating cancer using bcl-2 antisense oligomers, tyrosine kinase inhibitors, and chemotherapeutic agents |
| 09/04/2008 | WO2008057503A3 Compositions including triciribine and taxanes and methods of use thereof |
| 09/04/2008 | WO2008055666A8 Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety |
| 09/04/2008 | WO2008054956A3 Kinase inhibitors |
| 09/04/2008 | WO2008054693A9 Uses of tetrahydrobiopterin and derivatives thereof |
| 09/04/2008 | WO2008048205A3 Method for delivering hydrophobic drugs via nanocrystal formulations |
| 09/04/2008 | WO2008047229A3 Biaryl ether urea compounds |
| 09/04/2008 | WO2008042898A9 Ketoconazole enantiomer in humans |
| 09/04/2008 | WO2008042755A3 Inhibitors of cognitive decline |
| 09/04/2008 | WO2008040361A3 Use of a combination of hypothermia inducing drugs |
| 09/04/2008 | WO2008033746A3 Tyrosine kinase inhibitors containing a zinc binding moiety |
| 09/04/2008 | WO2008029264A3 Method of treating bone cancer |
| 09/04/2008 | WO2008019996A3 Formulations of flibanserin and method for manufacturing the same |
| 09/04/2008 | WO2008019063A3 Defoliant composition and method |
| 09/04/2008 | WO2008014393A3 Non-invasive in-vivo imaging of mechanoreceptors in skin using confocal microscopy |
| 09/04/2008 | WO2008012666A3 Treatment and prevention mucositis by anthocyanidin derivatives |
| 09/04/2008 | WO2008011381A3 Treatment of pain through expression of opioid receptors |
| 09/04/2008 | WO2008011364A3 Quercetin-containing compositions |
| 09/04/2008 | WO2008008215A3 Method for enhancing pdt efficacy using a tyrosine kinase inhibitor |
| 09/04/2008 | WO2008005783A3 Treatment of non- infectious inflammatory vulvovaginitis with a bioadhesive clindamycin composition |
| 09/04/2008 | WO2008000513A3 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/04/2008 | WO2008000429A3 Polymers with antimicrobial activity containing quaternary ammonium groups |
| 09/04/2008 | WO2007149523A3 Hexahydro-isoalpha acid based protein kinase modulation cancer treatment |
| 09/04/2008 | WO2007149508A3 Non-competitive nmda receptor antagonists |
| 09/04/2008 | WO2007144195A3 Pharmaceutical composition with synergistic anticonvulsant effect |
| 09/04/2008 | WO2007142967A3 Alcohol-containing antimicrobial compositions having improved efficacy |
| 09/04/2008 | WO2007139826A3 Method for elevating prolactin in mammals |
| 09/04/2008 | WO2007132293A3 Once-daily administration of central nervous system drugs |
| 09/04/2008 | WO2007126988A3 Selective androgen receptor modulators and methods of use thereof |
| 09/04/2008 | WO2007121924A3 Bisadenosine compounds as adenosine a2a receptor agonists |
| 09/04/2008 | WO2007117544A3 Carnitine conjugates of adamantanamines and neramexane derivatives as duel prodrugs for various uses |
| 09/04/2008 | WO2007109582A3 Method of treating pulmonary edema or pulmonary inflammation |
| 09/04/2008 | WO2007109312A3 Disease modifying anti-arthritic activity of 2-methoxyestradiol |
| 09/04/2008 | WO2007103770A3 Compositions and methods for analyzing renal cancer |
| 09/04/2008 | WO2007100624A3 Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver |
| 09/04/2008 | WO2007099302A8 Methods of maintaining oral health in animals using morpholine derivatives |
| 09/04/2008 | WO2007098142A3 Oxazole ketones as modulators of fatty acid amide hydrolase |
| 09/04/2008 | WO2007092414A8 Use of phosphatases to treat tumors overexpressing n-cor |
| 09/04/2008 | WO2007071861A8 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof |
| 09/04/2008 | WO2007054776A3 Stilbene like compounds as novel hdac inhibitors |
| 09/04/2008 | US20080216184 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 09/04/2008 | US20080215122 Plasmonic engineering of singlet oxygen and/or superoxide generation |
| 09/04/2008 | US20080215032 Minimizing Metal Toxicity During Electroporation Enhanced Delivery of Polynucleotides |
| 09/04/2008 | US20080214870 Method of Preparing Amine Stereoisomers |
| 09/04/2008 | US20080214853 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 09/04/2008 | US20080214851 Synthesis of labeled fatty acid analogs for use in tomography |
| 09/04/2008 | US20080214849 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium |
| 09/04/2008 | US20080214820 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc. |
| 09/04/2008 | US20080214812 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 09/04/2008 | US20080214802 Treating sepsis, septicemia and septic shock |
| 09/04/2008 | US20080214677 Chitosan-Silicon Dioxide Coprecipitate and Use as Excipient in Solid Dosage Forms |
| 09/04/2008 | US20080214676 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors |
| 09/04/2008 | US20080214675 Hydroxybenzoic Acid Amides and the Use Thereof For Masking Bitter Taste |
| 09/04/2008 | US20080214674 Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction |
| 09/04/2008 | US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds |
| 09/04/2008 | US20080214672 Treatment of Asthma with Aryl Sulfonamides |
| 09/04/2008 | US20080214671 Administering dicarbonic acids as metastasis inhibitors and agents enhancing chemotherapeutic activity of anti-tumor agents; in combination with cisplatin at the minimum doses, completely inhibiting the metastasis process in experimental B-16 melanoma |
| 09/04/2008 | US20080214670 Therapeutic Malonic Acid/Acetic Acid C60 Tri-Adducts of Buckminsterfullerene and Methods Related Thereto |
| 09/04/2008 | US20080214669 Hydroxycinnamic acid, a methoxycinnamic acid, dissolved in a compound having hydroxy groups; lightening skin |
| 09/04/2008 | US20080214668 Use of retinoids to treat high blood pressure and other cardiovascular disease |